Log In
Print
BCIQ
Print
Print this Print this
 

tabalumab (LY2127399)

Also known as: Anti-BAFF antibody

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionHuman IgG4 mAb targeting BLyS (BAFF)
Molecular Target BLyS (BAFF)
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today